A Minimal lncRNA-mRNA Signature Predicts Sensitivity to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

A Minimal lncRNA-mRNA Signature Predicts Sensitivity to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Background/Aims: Triple-negative breast cancer (TNBC) is a highly aggressive malignancy that responds in a diverse manner to neoadjuvant chemotherapy (NAC). This study was aimed to uncover an RNA signature in TNBC patients which predicts pathological complete responses (pCR) to NAC by analyzing long...

Full description

Bibliographic Details
Main Authors: Qian Wang, Chunmei Li, Peipei Tang, Runyuan Ji, Song Chen, Jian Wen
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2018-08-01
Series:Cellular Physiology and Biochemistry
Subjects:
Triple-negative breast cancer
Neoadjuvant chemotherapy
Response
Gene signature
LncRNA
Online Access:https://www.karger.com/Article/FullText/492698

Internet

https://www.karger.com/Article/FullText/492698

Similar Items